NASDAQ:ITMR

Itamar Medical (ITMR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$30.87
$30.87
50-Day Range
$30.54
$30.87
52-Week Range
$16.36
$30.91
Volume
N/A
Average Volume
90,796 shs
Market Capitalization
$497.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ITMR stock logo

About Itamar Medical Stock (NASDAQ:ITMR)

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

ITMR Stock News Headlines

ITMR Historical Data
They say it’s ‘unstoppable’ – How I made 43,509%
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
Read Your Way Around the World
Find the Best Medical Schools
Sarit Packer and Itamar Srulovich
ZOLL Announces Closing of Acquisition of Itamar Medical
They say it’s ‘unstoppable’ – How I made 43,509%
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
Itamar Medical ADSs Rally on Zoll Medical Deal >ITMR
Itamar Medical Earnings Miss, Revenue Beats In Q2
See More Headlines
Receive ITMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Itamar Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/18/2021
Today
4/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ITMR
Fax
N/A
Employees
257
Year Founded
1997

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$41.03 million

Miscellaneous

Free Float
N/A
Market Cap
$497.25 million
Optionable
Not Optionable
Beta
0.73

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Gilad Glick
    President, CEO & VP-Sales & Marketing
  • Shy Basson
    Chief Financial Officer
  • Efrat Litman
    Vice President-Advanced Research & Development
  • Jennifer Cook
    Global Medical Director
  • Eilon Livne
    VP-Sales & Channels Development

ITMR Stock Analysis - Frequently Asked Questions

How were Itamar Medical's earnings last quarter?

Itamar Medical Ltd. (NASDAQ:ITMR) released its quarterly earnings results on Thursday, November, 18th. The company reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.32. The firm had revenue of $13.57 million for the quarter, compared to the consensus estimate of $13.70 million.

What other stocks do shareholders of Itamar Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Itamar Medical investors own include Gilead Sciences (GILD), AbbVie (ABBV), Carnival Co. & (CCL), Energy Transfer (ET), KeyCorp (KEY), Occidental Petroleum (OXY), Pfizer (PFE), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

Does Itamar Medical have any subsidiaries?
The following companies are subsidiares of Itamar Medical: I.M.E. 2016 B.V., Itamar Medical Inc., and Itamar Medical Japan Co. Ltd..
Read More
This page (NASDAQ:ITMR) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners